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Abstract
Diminished adult neurogenesis is considered a potential mechanism in the pathogenesis of HIV-1-associated dementia
(HAD). In HAD, HIV-1-infected and immune-activated brain mononuclear phagocytes (MP; perivascular macrophages and
microglia) drive central nervous system (CNS) inflammation and may alter normal neurogenesis. We previously
demonstrated HIV-1-infected and lipopolysaccharide (LPS) activated monocyte-derived macrophages (MDM) inhibit human
neural progenitor cell (NPC) neurogenesis, while enhancing astrogliogenesis through the secretion of the inflammatory
cytokines such as tumor necrosis factor-alpha (TNF-a), in vitro and in vivo. Here we further test the hypothesis that HIV-1-
infected/activated MDM promote NPC astrogliogenesis via activation of the transcription factor signal transducer and
activator of transcription 3 (STAT3), a critical factor for astrogliogenesis. Our results show that LPS-activated MDM-
conditioned medium (LPS-MCM) and HIV-infected/LPS-activated MDM-conditioned medium (LPS+HIV-MCM) induced Janus
kinase 1 (Jak1) and STAT3 activation. Induction of the Jak-STAT3 activation correlated with increased glia fibrillary acidic
protein (GFAP) expression, demonstrating an induction of astrogliogenesis. Moreover, STAT3-targeting siRNA (siSTAT3)
decreased MCM-induced STAT3 activation and NPC astrogliogenesis. Furthermore, inflammatory cytokines (including IL-6,
IL-1b and TNF-a) produced by LPS-activated and/or HIV-1-infected MDM may contribute to MCM-induced STAT3 activation
and astrocytic differentiation. These observations were confirmed in severe combined immunodeficient (SCID) mice with
HIV-1 encephalitis (HIVE). In HIVE mice, siRNA control (without target sequence, sicon) pre-transfected NPCs injected with
HIV-1-infected MDM showed more astrocytic differentiation and less neuronal differentiation of NPCs as compared to NPC
injection alone. siSTAT3 abrogated HIV-1-infected MDM-induced astrogliogenesis of injected NPCs. Collectively, these
observations demonstrate that HIV-1-infected/activated MDM induces NPC astrogliogenesis through the STAT3 pathway.
This study generates important data elucidating the role of brain inflammation in neurogenesis and may provide insight
into new therapeutic strategies for HAD.
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Introduction
Active neurogenesis occurs throughout life and relies upon the
proliferation, migration, and proper differentiation of neural stem/
progenitor cells (NPCs) [1,2]. Diminished adult neurogenesis is
considered a potential factor in the pathogenesis of neurodegen-
erative diseases, including HIV-1-associated dementia (HAD),
multiple sclerosis, Parkinson’s, and Alzheimer’s diseases
[3,4,5,6,7,8,9]. Several studies have suggested a close linkage
between the inflammatory reaction of the injured brain and the
neurogenesis process [5,10,11,12,13]. Given that neurogenesis is
affected by inflammatory states, we sought to determine
mechanistically how HIV-mediated inflammatory may influence
neurogenesis.
During HAD, HIV-1-infected and immune-activated brain
mononuclear phagocytes (MP; perivascular macrophages and
microglia) release many immune competent factors including
cytokines, viral proteins and neurotoxins. These factors are
involved in neuronal injury, drive central nervous system (CNS)
inflammation, and may alter normal neurogenesis [14,15,16,17,
18,19]. Ithasbeenshownthat HAD patients have feweradult NPCs
in the dentate gyrus of the hippocampus than non-infected subjects
or HIV-1-infected patients without dementia [20,21]. Moreover,
analysis of the basal ganglia of severe combined immunodeficient
(SCID) mice revealed inhibition of hippocampal neurogenesis
following injection with HIV-1-infected human MP [7]. Our
previous work demonstrated HIV-1-infected and immune-activated
monocyte-derived macrophages (MDM) inhibit neurogenesis, while
enhancing astrogliogenesis through secretion of inflammatory
cytokines such as IL-1b and TNF-a [9]. However, the signaling
pathways involved in this process are unknown.
The signal transducer and activator of transcription (STAT) 3
signaling pathway plays a critical role in NPC differentiation,
particularly in enhancing astrocytic differentiation (astrogliogen-
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Janus Kinase-STAT3 (Jak-STAT3) pathway result in impaired
astrocytic differentiation in vivo [22,23,24,25]. In addition to the
well-established role in development [24,26,27], the STAT3
pathway also contributes to microglial cell-induced astrogliogen-
esis [28,29].
Using a primary human NPC culture system and a SCID HIV-
1 encephalitis (HIVE) mouse model, we demonstrate that the
STAT3 pathway is crucial for HIV-1-infected and immune-
activated MDM-induced NPC astrogliogenesis and provide
evidence that this effect is at least partially mediated by the action
of TNF-a.
Materials and Methods
Monocyte cell culture and conditioned medium
collection
Human monocytes were recovered from peripheral blood
mononuclear cells (PBMCs) of HIV-1 and hepatitis B seronegative
donors after leukopheresis and counter-current centrifugal elutri-
ation [30]. Monocytes were cultured as adherent monolayer at a
density of 1.1 610
6 cells/well in 24-well plates and cultivated in
Dulbecco’s modified Eagles medium (DMEM, Invitrogen, Carls-
bad, CA) with 10% heat-inactivated pooled human serum
(Cambrex Bio Science, Walkersville, MD), 50 mg/ml gentamicin
and/or 10 mg/ml ciprofloxacin (Sigma-Aldrich, St. Louis, IL) and
1000 U/ml highly purified recombinant human macrophage
colony stimulating factor (MCSF, a generous gift from Wyeth
Institute, Cambridge, MA).
Seven days after plating, human monocyte-derived macrophag-
es (MDM) were infected with HIV-1 strain ADA at a multiplicity
of infection (MOI) of 0.1virus/target cell [31]. Three to four days
after infection HIV-1-infected and replicate uninfected MDM
were then treated with/without lipopolysaccharide (LPS) (Sigma-
Aldrich, 0.1 mg/ml) for 3 h. Cells were then rinsed two times with
fresh DMEM to remove residual LPS, and serum-free DMEM
was placed onto the MDM for 24 h. The MDM conditioned
medium (MCM) was harvested, cleared of free-floating cells by
centrifugation for 5 min at 1200 rpm, and stored at 280uC.
MDM were fixed in 4% paraformaldehyde for p24 staining as
described in the Immunocytochemistry section.
Neural progenitor cell culture
Human cortical NPCs were isolated from human fetal brain
tissue as previously described [32]. NPCs were cultured in
substrate-free tissue culture flasks and grown as spheres in
neurosphere initiation medium (NPIM), which consisted of X-
Vivo 15 (BioWhittaker, Walkersville, ME) with N2 supplement
(Invitrogen), neural cell survival factor-1 (NSF-1, BioWhittaker),
basic fibroblast growth factor (bFGF, 20 ng/ml, Sigma-Aldrich),
epidermal growth factor (EGF, 20 ng/ml, Sigma-Aldrich), leuke-
mia inhibitory factor (LIF, 10 ng/ml, Chemicon, Temecula, CA),
and 60 ng/ml N-acetylcysteine (Sigma-Aldrich). Cells were
passaged at two-week intervals as previously described [32].
Human neural progenitor cell differentiation
Following a protocol frequently used to induce neuronal
differentiation of NPC [32,33,34], dissociated NPCs were plated
on poly-D-lysine-coated cell culture dishes or coverslips (Sigma-
Aldrich). Cells were cultured in NPIM for 24 h and subsequently
changed to serum-free Neurobasal medium (Invitrogen) supple-
mented with B27 (Invitrogen, NB27) with or without MCM or
cytokines. For the inhibition of TNF-a, MCM was pre-incubated
with TNF-a soluble receptors R1 and R2 (TNF-R1R2, each
100 ng/ml, R&D Systems, Minneapolis, MN) for 1 h at 37uC. For
siRNA transfection, pre-designed siRNA duplexes targeted against
STAT3 mRNA (siSTAT3) were synthesized by Ambion Inc.
(Austin, Texas). NPCs were transfected with 100 nM nonspecific
control siRNA (sicon) or siSTAT3 in the presence of siImporter
(Upstate Cell Signaling Solutions, Charlot-tesville, VI) according
to the manufacturer’s instructions. Twenty-four hours later, cells
were treated with MCM to one to six days. Cells were fixed for
immunocytochemical staining and protein or RNA was collected
for Western blot or RT-PCR.
Immunocytochemistry
Cells were fixed in 1:1 methanol/acetone and washed in PBS as
previously described [32]. Cells were then incubated overnight
with mouse or rabbit anti-b-III-tubulin (Sigma-Aldrich, 1:400) for
the identification of neurons or rabbit anti-GFAP (glial fibrillary
acidic protein, Dako, Carpinteria CA, 1:1000) for the identifica-
tion of astrocytes, followed by Alexa Fluor secondary antibodies,
goat anti-mouse IgG Alexa Fluor 488 and goat anti-rabbit IgG
Alexa Fluor 594 (Molecular Probes, Eugene, OR, 1:400) for 1 h at
room temperature. To detect HIV-1 infection, MDM were fixed
in 4% paraformaldehyde for 20 min at room temperature and
washed in PBS three times. Cells were then incubated overnight
with p24 antibody (Dako, 1:100), followed by goat anti-mouse IgG
Alexa Fluor 488. All antibodies were diluted in PBS with 0.1%
Triton X-100 and 2% BSA. Cells were counterstained with
Hoechst 33342 (Sigma-Aldrich). Morphological changes were
visualized and captured with a Nikon Eclipse E800 microscope
equipped with a digital imaging system. Images were imported
into Image-ProPlus, version 7.0 (Media Cybernetics, Sliver Spring,
MD) for quantification. Ten to fifteen random fields (total 500–
1000 cells per culture) of immunostained cells were manually
counted using a 206objective.
Western blotting
Cells were rinsed twice with PBS and lysed by M-PER Protein
Extraction Buffer (Pierce, Rockford, IL) containing 16 protease
inhibitor cocktail (Roche Diagnostics, Indianapolis, IN). Protein
concentration was determined using a BCA Protein Assay Kit
(Pierce). Proteins (20–30 mg) were separated on a 10% SDS-
polyacrylamide gel electrophoresis (PAGE) and then transferred to
an Immuno-Blot polyvinylidene fluoride (PVDF) membrane (Bio-
Rad, Hercules, CA). After blocking in PBS/Tween (0.01%) with
5% nonfat milk, the membrane was incubated with primary
antibodies (phospho- and total-Jak1, Millipore; phospho- and
total-STAT3, Cell Signaling Technologies; b-actin, GFAP, and b-
III-tubulin, Sigma-Aldrich) overnight at 4uC followed by horse-
radish peroxidase-conjugated secondary antibodies (1:10,000; Cell
Signaling Technologies) and then developed using Enhanced
Chemiluminescent (ECL) solution (Pierce). For data quantification
the films were scanned with a CanonScan 9950F scanner and the
acquired images were then analyzed on a Macintosh computer
using the public domain NIH image program (developed at the
U.S. National Institutes of Health and available on the internet at
http://rsb.info.nih.gov/nih-image/).
ELISA
Supernatants from MDM were collected for cytokine determi-
nation by an in house ELISA (for paired antibodies, R&D
Systems). In Brief, 96-well microplates (Costar) were coated
overnight at room temperature with a capture antibody in PBS.
After three washes with PBS containing 0.05% Tween 20 (PBST),
non-specific binding was blocked for 2 h with 1% BSA in PBS.
Triplicate samples (100 ml) or a serial dilution of standards of
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wells and incubated overnight at 4uC. Plates were then incubated
for 1 h at room temperature with the biotinylated detection
antibody, followed by 30 min incubation with Streptavidin-HRP
(R&D Systems). After three washes with PBST, 100 ml Substrate
Solution (Tetramethylbenzidine, R&D Systems) was added to each
well for 5 to 20 min, followed by the addition of 50 ml of Stop
Solution (2N H2SO4, R&D System) to each well. The optical
density of each well was determined using a microplate reader
(Bio-Rad) set to 450 nm.
NPC and MDM injections into SCID mice
Four-week-old male CB-17(SCID) mice were purchased from
Jackson Laboratory (Bar Harbor, ME). Animals were maintained
in sterile microisolator cages under pathogen-free conditions in the
DRCI Animal Facility at UNMC, in accordance with ethical
guidelines for care and use of laboratory animals set forth by the
National Institutes of Health. NPCs were transfected with sicon or
siSTAT3. Twenty-four hours later, NPCs were labeled with
Qtracker (Invitrogen) following the manufacture’s protocol. NPCs
(sicon-NPC and siSTAT3-NPC) with or without HIV-1ADA-
infected MDM (sicon-NPC+MDM and siSTAT3-NPC+MDM,
1:4, total 5610
5 cells in 5 ml) were injected intracranially by
stereotactic methods [35]. Four animals were included in each
group. Seven days after injection, mice were euthanized with
isoflurane and perfused transcardially with 25 ml of PBS and then
4% paraformaldehyde as previously described [36]. The brains
were rapidly removed and immersed in freshly depolymerized 4%
paraformaldehyde for 48 h and then cryoprotected by successive
24-h immersions in 10, 20, and 30% sucrose in Sorenson’s
phosphate buffer immediately before sectioning.
Immunohistochemistry and image analysis
Fixed, cryoprotected brains were frozen and sectioned in the
horizontal plane at 30 mm using a Cryostat (Leica Microsystems
Inc., Bannockburn, IL), with sections collected serially in PBS.
Antibodies to GFAP or b-III-tubulin were used for the detection of
astrocytes or neurons. Double-immunofluorescence staining was
performed using goat anti-mouse IgG Alexa Fluor 488 or goat
anti-rabbit IgG 594 as a secondary antibody (Molecular Probes).
All obtained images were imported into Image-ProPlus, version
7.0 (Media Cybernetics, Sliver Spring, MD) for quantifying levels
of GFAP- and b-III-tubulin-positive staining. Four sections from
each injection site were analyzed.
Statistical analyses
Data were expressed as means 6 SD (standard deviation). The
data were evaluated statistically by analysis of variance (ANOVA)
followed by the Tukey-test for paired observations. Significance
was considered to be p#0.05. To account for any donor-specific
differences, all experiments were performed with NPCs and
MDM from at least three donors. All assays were performed at
least two times, with triplicate or quadruplicate samples in each
assay.
Results
HIV-1-infected and/or LPS-activated MCM activate the
Jak-STAT3 pathway
The STAT3 pathway plays an important role in NPC
differentiation, particularly in enhancing astrocytic differentiation
and inhibiting neuronal differentiation. Our previous work
demonstrates HIV-1-infected and immune-activated macrophages
inhibit NPC neurogenesis while enhancing astrogliogenesis in vitro
and in vivo through secretion of inflammatory cytokines [9]. In this
study we have further investigated if astrogliogenesis induced by
secretion factors from HIV-1-infected and immune-activated
MDM is through the STAT3 pathway. We used HIV-1-infected
and/or LPS-activated MDM and human fetal cortical NPCs to
test the effect of secreted factors from MDM on NPC
differentiation.
Human fetal cortical NPCs were expanded as neurosphere in
NPIM as previous described [32]. Under these conditions, over
90% of NPCs were immunopositive for the cytoskeletric protein
nestin, a marker for multipotential precursors (Figure S1A–C)
whereas less than 10% of the cells expressed the neuronal marker
b-III-tubulin or the astrocytic marker GFAP (data not shown).
This suggests that the majority of the cells were in an
undifferentiated state.
To determine whether MCM activate the Jak-STAT3 pathway
in NPCs, immunoblots were performed on cell extracts treated
with or without con-MCM, LPS-MCM, HIV-MCM, and
LPS+HIV-MCM. NPCs were cultured in NPIM for 24 hours
and subsequently changed to NB27 medium with different
concentrations of MCM (10, 20, and 40%) for an additional
24 hours (Figure 1A). The quantification results show both LPS-
MCM and LPS+HIV-MCM induced a dose-dependent increase
of Jak-1 (Figure 1B) and STAT3 (Figure 1C) activation. Although
HIV-MCM did not induce phosphorylation of Jak1 and STAT3,
LPS+HIV-MCM more robustly activated Jak1 and STAT3 as
compared to LPS-MCM (Figure 1B–C), suggesting HIV infection
potentiates LPS-MCM-induced Jak/STAT3 activation. In addi-
tion, both LPS-MCM and LPS+HIV-MCM induced increases of
total-Jak1 expression as compared to control (Figure 1D). The
MCM effect on total-Jak1 was similar to that on Jak1
phosphorylation (40% LPS+HIV-MCM induced 3.5-fold increase
in phospho-Jak1 and 3.6-fold increase in total-Jak1), suggesting
that the increase in MCM-induced Jak1 phosphorylation may be
due to the overall increase of total-Jak1.
To confirm the effect of MCM is time-dependent, we treated
NPCs with 20% control-MCM, LPS-MCM, HIV-MCM, and
LPS+HIV-MCM at time points ranging from 15 minutes to six
days and immunoblots were performed on cell extracts
(Figure 2B). The quantification results show that MCM-induced
STAT3 activation began at 15 minutes post treatment and first
peaked between 15–30 minutes (Figure 2C). Activation of
STAT3 was sustained at all time points indicated up until six
days and increased during cell differentiation. Maximal activa-
tion of STAT3 was observed at six days post treatment.
(Figure 2C).
To confirm that LPS+HIV-MCM-induced STAT3 activation
occurs in NPCs, we performed immunocytochemical studies with
NPC culture using a phospho-STAT3 antibody and an antibody
against nestin, a neural progenitor cell marker. Upon LPS+HIV-
MCM treatment, we found obvious nuclear-localized phosphor-
ylation of STAT3 as compared to con-MCM group (Figure 2A).
The results also show p-STAT3 highly co-localized with nestin-
positive cells (Figure 2A and Figure S1D–F). To detect if
LPS+HIV-MCM induce STAT3 activation in differentiated
astrocytes, which exist in NPC culture at a low percentage (less
than 10%), we treated NPCs with LPS+HIV-MCM and did
immunocytochemical studies using antibodies for p-STAT3 and
GFAP, an astrocyte marker (Figure S1G–I). The results show that
although some GFAP-positive cells were also p-STAT3-positive,
the majority of p-STAT3-positive cells were GFAP-negative
(Figure S1I). So we consider that the p-STAT3 signal observed
in Western blot analysis originated primarily from nestin-positive
NPCs.
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astrogliogenesis is through the Jak-STAT3 pathway
Next we investigated the role of the STAT3 pathway in MCM-
mediated astrocytic differentiation by inhibition of STAT3
expression using siRNA. To evaluate the transfection efficiency
in human NPCs, cells were first transfected with fluorescence-
labeled control siRNA (siGLO) and analyzed by flow cytometry
(Figure 3A). The transfection efficiency of siGLO reached 60%
24 hours post-transfection (Figure 3A). Gene expression analysis
using realtime RT-PCR found that siSTAT3 decreased 70% of
the STAT3 mRNA expression as compared to sicon-transfected
NPCs at 24 h post-transfection (Figure 3B). siSTAT3 showed the
similar effect on STAT3 mRNA expression at 48 h post-
transfection (data not shown), so we started MCM treatment at
24 h post-transfection for the following experiments.
To test whether HIV-1-infected and/or activated MDM-
induced astrogliogenesis is through the STAT3 pathway, NPCs
were transfected with siSTAT3 or sicon and then differentiated
with or without HIV-1-infected and/or LPS-activated MCM for
6 days. The effect of siSTAT3 on astrocytic differentiation was
first determined by realtime RT-PCR (Figure 3C, D). NPCs
treated with LPS-MCM and LPS+HIV-MCM displayed in-
creased GFAP (astrocyte marker) mRNA expression (Figure 3C)
and decreased MAP-2 (neuronal marker) mRNA expression
(Figure 3D), demonstrating an induction of astrogliogenesis and
inhibition of neurogenesis. Although HIV-MCM did not induce a
significant effect on GFAP mRNA expression, LPS+HIV-MCM
displayed a more dramatic increase of GFAP mRNA expression
as compared to LPS-MCM (Figure 3C). Conversely, knockdown
of STAT3 by siRNA inhibited the LPS-MCM and LPS+HIV-
MCM-induced increase of GFAP expression (Figure 3C) and the
decrease of MAP-2 expression (Figure 3D) at six days post-
transfection, suggesting that decreased STAT3 expression
abrogates LPS-MCM and LPS+HIV-MCM-induced astroglio-
genesis.
We next utilized Western blot to examine whether siSTAT3
could modulate HIV-1-infected and/or LPS-activated MCM-
induced STAT3 activation and NPC differentiation (Figure 4). In
agreement with mRNA expression, we found that STAT3 protein
expression was decreased in siSTAT3-transfected NPCs
(Figure 4A, C). While LPS-MCM and LPS+HIV-MCM signifi-
cantly increased STAT3 activation, siSTAT3 dramatically
decreased LPS-MCM and LPS+HIV-MCM-induced STAT3
phosphorylation (Figure 4A, B). Furthermore, LPS-MCM and
LPS+HIV-MCM increased GFAP expression, while siSTAT3
inhibited these changes (Figure 4A, D). However, we did not
observe a decrease of b-III-tubulin (neuronal marker) expression
by LPS-MCM and LPS+HIV-MCM stimulation. The possible
Figure 1. LPS-activated and/or HIV-1-infected MCM induce dose-dependent Jak-STAT3 activation in Human NPCs. A. Human NPCs
were treated with 10, 20, and 40% con-MCM, LPS-MCM, HIV-MCM, or LPS+HIV-MCM for 24 h. Expression of phospho-Jak1 (p-Jak1), phospho-STAT3
(p-STAT3), total-Jak1 and total-STAT3 were detected by Western blotting. b-actin was used as a loading control. Results are representative of three
independent experiments. B–D. The films were scanned and the acquired images were analyzed using the public domain NIH image program for
data quantification. Expression of phospho-Jak1 (B), phospho-STAT3 (C), and total-Jak1 (D) were normalized to b-actin. Data is presented as fold of
control expression. Results are average of three independent donors. * p,0.05 in comparison to control, # p,0.05 in comparison to LPS-MCM of the
same concentration.
doi:10.1371/journal.pone.0019439.g001
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to show the changes of b-III-tubulin protein.
To validate whether the increase of GFAP is due to the increase
in the number of astrocytes, the effect of the STAT3 pathway on
MCM-induced astrogliogenesis was further tested by immunocy-
tochemistry. NPCs were transfected with siSTAT3 and sicon and
then differentiated with or without HIV-1-infected and/or
immuno-activated MCM for six days. Expression of differentiation
markers was evaluated by immunostaining with antibodies against
b-III-tubulin or GFAP (Figure 5). LPS+HIV-MCM treatment
significantly increased the proportion of the GFAP-positive cells
(Figure 5E), while LPS- and LPS+HIV-MCM treatment signifi-
cantly decreased the proportion of the b-III-tubulin-positive cells
(Figure 5F). As expected, siSTAT3 significantly inhibited
LPS+HIV-MCM-induced astrogliogenesis (Figure 5E, from 1.20
6 0.13 to 0.95 6 0.19, p , 0.01) and partially abrogated the
inhibition of neurogenesis induced by LPS+HIV-MCM (Figure 5F,
from 0.31 6 0.13 to 0.49 6 0.18, p , 0.01).
Taken together, these results suggest that HIV-1-infected and
immune-activated MCM promote astrogliogenesis through the
STAT3 pathway.
TNF-a contributes to immune-activated and/or HIV-1-
infected MCM-induced STAT3 activation and
astrogliogenesis
Previous studies demonstrated that TNF-a is elevated in
immune activated and/or HIV-1-infected MDM and contributes
to LPS-activated and/or HIV-infected MCM-induced astroglio-
genesis [9]. Thus we tested whether TNF-a could induce STAT3
activation. We treated NPCs with TNF-a (20 ng/ml) at time
points ranging from 1 min to 24 h. The results show that TNF-a
induced late activation of STAT3 (started at 4 h and sustained to
24 h, Figure 6A).
To assess whether TNF-a is responsible for inducing STAT3
activation in NPCs treated with HIV-1-infected and/or LPS-
activated MCM, MCM were pre-incubated with TNF soluble
receptors (100 ng/ml) before the treatment. The results show that
TNF-R1R2 partially reduced LPS+HIV-MCM-induced STAT3
activation (from 8.2661.00 to 6.0361.05 fold as compared to
NB27, Figure 6B–C). Pre-incubation with TNF-R1R2 also
partially reduced LPS+HIV-MCM-induced astrocytic differentia-
tion as shown by GFAP expression (from 4.2260.52 to 2.7460.47
fold as compared to NB27, Figure 6B, D). These results indicate
that TNF-a, derived from immune-activated and/or HIV-1-
infected MDM, contributes to MCM-induced astrogliogenesis via
the STAT3 pathway.
HIV-1-infected MDM morphology and analysis of
cytokine levels in LPS-activated and/or HIV-1-infected
MCM
To evaluate HIV infection efficiency at the time of MCM
collection, we utilized immunostaining for the p24 protein of HIV,
the capsid protein of the virus.
Seven days after plating, we exposed MDM to HIV-1 strain
ADA at a multiplicity of infection (MOI) of 0.1virus/target cell
[31]. Three to four days after exposure to HIV-1, HIV-1-infected
MDM merged into multi-nuclear giant cells (Figure S2D-F). These
cells were then stimulated with LPS for 3 h and MCM was
harvested 24 h after stimulation. The HIV-1 infection efficiency
was assessed by immunostaining for the p24 protein of HIV-1. An
average of 61.169.6% of the cells were positive for the expression
of HIV-1 p24 in the HIV-1-infected group (HIV, Figure S2D-F).
The LPS-stimulated group showed a lower trend of HIV-1
infection efficiency (48.1620.5%, HIV+LPS, Figure S2G–H), but
not statistically different when compared to the HIV-1-infected
group without LPS stimulation (Figure S2J).
TNF-R1R2 only partially reduced LPS+HIV-MCM-induced
STAT3 activation and astrogliogenesis, so we used ELISA to
investigate several inflammatory factors secreted by macrophages/
microglia that are considered to induce astrogliogenesis. Among
the cytokines examined, the protein level of LIF in MCM was very
low (less than 3 pg/ml, data not shown). IL-6, IL-1b, and TNF-a
Figure 2. LPS-activated and/or HIV-1-infected MCM induce
sustained STAT3 activation in human NPCs. A. Human NPCs were
treated with or without 20% LPS+HIV-MCM for 24 h. Cells were
immunolabeled with antibodies to NPC marker Nestin (green) and
phospho-STAT3 (p-STAT3, red). Nuclei were stained with Hoechst (blue).
Results are representative of two independent experiments. Original
magnification is 660. B. NPCs were treated with 20% con-MCM, LPS-
MCM, HIV-MCM, or LPS+HIV-MCM for 15 min, 30 min, 4 h, 8 h, 24 h,
4 d, and 6 d. Expression of p-STAT3 was detected by Western blotting
and normalized to b-actin. C. The films were scanned and the acquired
images were analyzed using the public domain NIH image program for
data quantification. Expression of p-STAT3 was normalized to b-actin.
Data is presented as fold of control expression. Results are represen-
tative of two independent experiments.
doi:10.1371/journal.pone.0019439.g002
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1b, and TNF-a production by MDM (0.73460.710 ng/ml for IL-
6, 0.02660.007 ng/ml for IL-1b, 0.65960.098 ng/ml for TNF-
a), LPS+HIV induced a more dramatic increase of cytokine
production (2.39661.081 ng/ml for IL-6, 0.21260.104 ng/ml for
IL-1b, 4.18063.043 ng/ml for TNF-a, Figure S2K–M). These
observations suggest that although HIV-1 infection alone did not
induce a significant effect on IL-6, IL-1b, and TNF-a expression,
HIV-1 infection potentiated LPS-stimulated cytokine production.
The observed cytokine expression pattern correlates with LPS-
MCM and LPS+HIV-MCM-induced STAT3 activation and
astrogliogenensis, suggesting IL-6 and IL-1b may also contribute
to MCM-induced STAT3 activation and astrogliogenesis.
siSTAT3 inhibits HIV-1-infected MDM-induced NPC
astrogliogenesis in HIVE mice
To investigate the role of the STAT3 pathway in HIV-1-
infected macrophage-mediated NPC astrogliogenesis in vivo,w e
used an HIVE SCID mouse model [9]. Human NPCs transfected
with siSTAT3 or sicon were intracranially injected into the basal
ganglia of SCID mice with or without HIV-1ADA-infected MDM.
Seven days after injection, NPC differentiation was identified
throughout the injected hemisphere by immunostaining in serial
30 mm brain sections (Figure 7). Confocal images show that the
injected human NPCs survived and differentiated into neurons (b-
III-tubulin-positive, green, Figure 7A) and astrocytes (GFAP-
positive, red, Figure 7A). Neuronal and astrocytic differentiation
were quantified by determining the percentage of GFAP-positive
or b-III-tubulin-positive cells in the injection area. HIV-1ADA-
infected MDM increased astrocytic differentiation (Figure 7B) and
decreased neuronal differentiation (Figure 7C) compared to NPC
injected alone. Additionally, siSTAT3 abrogated HIV-1-infected
MDM induced-astrocytic differentiation of NPCs as compared to
NPCs transfected with sicon. This data further confirms that HIV-
1-infected MDM induce NPC astrocytic differentiation in vivo via
activation of the STAT3 pathway, while decreased action of the
STAT3 pathway lowers astrogliogenesis and induces more
neuronal differentiation of NPCs.
Discussion
Previous work in our lab has demonstrated that HIV-1-infected
and immune-activated MDM inhibit NPC neurogenesis, while
enhancing astrogliogenesis both in vitro and in vivo. To extend on
our previous findings, we examined the function of the Jak-STAT3
pathway, a crucial part of the astrogliogenic machinery, in HIV-1-
infected and/or immune-activated MCM-induced NPC differen-
tiation. We found that LPS-MCM induces activation of STAT3
and LPS+HIV-MCM induces more dramatic activation of
STAT3 as compared to LPS-MCM (Figure 1–2). siRNA-mediated
knockdown of STAT3 expression results in a reduction of MCM-
induced STAT3 activation and astrocytic differentiation (Figure 3–
5) in vitro. siSTAT3 also reduced HIV-1-infected MDM-induced
astrogliogenesis in vivo (Figure 7). Furthermore, inflammatory
Figure 3. siRNA for STAT3 inhibits LPS-activated and/or HIV-1-infected MCM-induced astrogliogenesis by realtime RT-PCR. A. NPCs
were transfected with fluorescence-labeled control siRNA (siGLO) and analyzed by flow cytometry. The transfection efficiency of siGLO reached 60%
at 24 h post-transfection. B. NPCs were transfected with siSTAT3 or sicon for 24 h. STAT3 mRNA expression were detected by TaqMan realtime RT-
PCR and normalized to GAPDH as an internal gene expression control. Data are presented as fold of sicon. * p,0.05 in comparison to sicon.
C–D. NPCs were transfected with siSTAT3 or sicon for 24 h and then differentiated in NB27 medium with or without 20% con-MCM, HIV-MCM, LPS-
MCM, or LPS+HIV-MCM for 6 d. GFAP (C) and MAP-2 (D) mRNA expression were detected by TaqMan realtime RT-PCR and normalized to GAPDH as an
internal gene expression control. Data are presented as fold of NB27. * p,0.05 in comparison to NB27, # p,0.05 in comparison to LPS-MCM,
‘ p,0.05 in comparison to sicon of the same condition.
doi:10.1371/journal.pone.0019439.g003
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activated and/or HIV-1-infected MDM may contribute to MCM-
induced STAT3 activation and astrocytic differentiation (Figure 6
and Figure S2). Thus, we report here that HIV-1-infected and
immune-activated MDM promote astrogliogenesis through the
secretion of cytokines via the Jak-STAT3 pathway.
Activation of the Jak-STAT3 signaling pathway is considered
one of the main mechanisms promoting astrocytic differentiation
and inhibiting neuronal differentiation of neural stem/progenitor
cells [25,26,37,38]. Cytokines activate members of the Jak family,
which in turn activate, by tyrosine phosphorylation, one or more
members of the STAT family of transcription factors. Dimerized
STAT3 translocates to the nucleus and binds to the GFAP
promoter activating the transcription of GFAP [26,37]. Previous
work from other laboratories has demonstrated microglial-derived
soluble factors induce astrocytic differentiation through the
STAT3 pathway [29]. We further investigated the potential role
of the STAT3 pathway in HIV-infected and immune-activated
MDM. In this study, we found that although HIV-1-infected
MCM does not induce STAT3 activation and subsequent
astrocytic differentiation, HIV infection potentiates LPS-activated
MCM-induced STAT3 activation as compared to LPS-MCM
(Figure 1-2). The activation of Jak/STAT3 is correlated with the
up-regulation of GFAP transcription and protein expression,
which indicates MCM-induced astrogliogenesis may be through
the Jak1-STAT3 pathway. The requirement of this pathway in
astrocytic differentiation was investigated by inhibition of STAT3
expression. siRNA targeting STAT3 down-regulated STAT3
expression (Figure 3–4), decreased STAT3 activation induced by
MCM (Figure 4), and blocked astrocytic differentiation induced by
LPS-MCM and LPS+HIV-MCM (Figure 3–5) in vitro. Further-
more, siSTAT3 reduced HIV-1-infected MDM induced astro-
gliogenesis in the SCID mouse HIVE model (Figure 7). In
conclusion, our work further demonstrates that HIV-1-infected
Figure 4. siRNA for STAT3 inhibits LPS-activated and/or HIV-1-infected MCM-induced STAT3 activation and astrogliogenesis.
A. NPCs were transfected with siSTAT3 or sicon for 24 h and then differentiated in NB27 medium with or without 20% con-MCM, HIV-MCM, LPS-MCM,
or LPS+HIV-MCM for 6 d. Expression of p-STAT3, t-STAT3, GFAP, and b-III-tubulin was detected by Western blotting. Results are representative of
three independent experiments. B–E. The films were scanned and the acquired images were analyzed using the public domain NIH image program
for data quantification. Expression of phospho-STAT3 (B), STAT3 (C), GFAP (D), and b-III-tubulin (E) were normalized to b-actin. Data is presented as
fold of NB27 expression. Results are average of three independent donors. * p,0.05 in comparison to NB27, # p,0.05 in comparison to LPS-MCM, ‘
p,0.05 in comparison to sicon of the same condition.
doi:10.1371/journal.pone.0019439.g004
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Jak1-STAT3 pathway.
In mammals, the Jak-STAT3 pathway is the principal signaling
mechanism for a wide array of cytokines and growth factors.
Members of the IL-6 cytokine family such as, leukemia inhibitory
factor (LIF), IL-6 and ciliary neurotrophic factor (CNTF), can
activate the Jak-STAT signaling pathway and promote astroglial
differentiation [26,27]. Nakanishi et al. have reported that
activated microglia promote astrocytic differentiation of NSCs
through the release of cytokines, IL-6 and LIF [29]. We detected
IL-6 and LIF expression by HIV-1-infected and/or LPS-activated
MDM by real-time RT-PCR (data not shown) and ELISA. ELISA
results show that although LIF mRNA is detected in MDM, the
protein level of LIF in MCM is very low. Data demonstrate that
the level of IL-6 is elevated in LPS-MCM and LPS+HIV-MCM
(Figure S2K) and the expression pattern correlates with STAT3
activation and astrogliogenensis, suggesting IL-6 may contribute to
MCM-induced STAT3 activation and astrogliogenesis.
Our previous studies showed that TNF-a is produced by HIV-
1-infected and/or LPS-activated MDM and contributes to HIV-1-
infected and/or LPS-activated MCM-induced astrogliogenesis [9].
In this study, we further demonstrated TNF-a induces STAT3
activation in NPCs (Figure 6A). TNF-R1 and R2 partially
abrogate HIV-1-infected and/or LPS-activated MCM-induced
STAT3 activation and astrogliogenesis (Figure 6B–D), suggesting
TNF-a-derived from HIV-1-infected and/or LPS-activated-
MDM may contribute to MCM-induced STAT3 activation and
astrogliogenesis. However, TNF-a-induced STAT3 activation
does not coincide with the LPS-MCM and LPS+HIV-MCM-
induced STAT3 activation profile. While TNF-a-induced STAT3
activation starts four hours post-treatment (Figure 6A), LPS-MCM
and LPS+HIV-MCM-induced STAT3 activation began at 15
minutes and was sustained until six days (Figure 2). One possible
explanation for this temporal variance is that other soluble factors,
such as IL-6 and LIF, released from MDM may contribute to
MCM-induced early time point activation of STAT3. Preliminary
data from our lab demonstrated that human recombinant IL-6
induces a moderate increase of STAT3 activation, while LIF
induces a dramatic activation of STAT3 at early time point (15 to
30 min). However, the protein level of LIF in MCM is very low as
Figure 5. siRNA for STAT3 inhibits LPS-activated and/or HIV-1-infected MCM-induced increase of astrocyte and decrease of
neuronal proportions. NPCs were transfected with siSTAT3 or sicon for 24 h and were then differentiated in NB27 medium with or without 20%
con-MCM, HIV-MCM, LPS-MCM, or LPS+HIV-MCM for 6 d. A–D. Representative fluorescence overlay micrographs display the morphology of neurons
(green) and astrocytes (red) in sicon-transfected NPCs without treatment (sicon-NB27, A), siSTAT3-transfected NPCs without treatment (siSTAT3-NB27,
B), sicon transfected NPCs treated with LPS+HIV-MCM (C) or siSTAT3-transfected NPCs treated with LPS+HIV-MCM (D). Nuclei were stained with
Hoechst (blue). E–F. GFAP (E) or b-III-tubulin (F) positive cells were quantified; data is presented as fold of sicon-NB27 expression. Results are
representative of two independent experiments. * p,0.05 in comparison to sicon-NB27, # p,0.05 in comparison to LPS-MCM, ‘ p,0.05 in
comparison to sicon of the same condition.
doi:10.1371/journal.pone.0019439.g005
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and STAT3 activation induced by LPS- and LPS+HIV-MCM
suggests IL-6 may contribute to MCM-induced STAT3 activation
at early time points. The role of IL-6 and LIF in MCM-induced
STAT3 activation and astrogliogenesis may need to be further
investigated.
Both TNF-a (Figure 6A) and IL-1b (data not shown) induce
STAT3 activation at delayed time points, suggesting these
cytokines play an indirect role. Unpublished data from our lab
show that IL-1b and TNF-a induce NPC’s production of LIF and
IL-6, which could activate STAT3. These intermediate cytokines
may contribute to the delayed and sustained activation of STAT3
and subsequent astrogliogenesis induced by TNF-a and IL-1b.
However, the mechanisms by which IL-1b and TNF-a induce
production of LIF and IL-6 and subsequent astrogliogenesis
require further investigation.
The role played by microglia/macrophage in the regulation of
neurogenesis under specific pathological conditions is a matter of
hot debate [5,10,28,29,39,40]. In HAD, MP are the principal cells
infected by HIV and major mediators of the inflammatory
response within the brain. Following HIV-1 infection and immune
activation, MP undergo functional alterations that lead to the
secretion of cytokines thus inducing astrogliogenesis [9]. We
reasoned the interaction between MP and NPCs is a major aspect
for how neurogenesis is affected in a diseased brain. Our data,
consistent with findings from other groups [5,12,29,40], suggest
that acutely activated microglia/macrophage increase the per-
centage of GFAP-positive cells produced from NPCs via the
activation of the Jak-STAT3 pathway. Importantly, we also
demonstrated that once immune-activated, HIV-1-infected MP
induce more GFAP-positive cells from NPCs. This may contribute
to astrogliosis, an important pathological feature of HAD.
Although the enhancement of astrocyte generation could be
regarded as a potentially beneficial mechanism in neurodegener-
ative diseases given the role of astrocytes in synapse formation and
stabilization, identification of suitable tools to direct NPCs toward
the neuronal phenotype could represent a new strategy to enforce
endogenous brain regenerative processes.
A previous study using NSC culture showed that suppression of
STAT3 directly induces neurogenesis and inhibits astrogliogenesis
Figure 6. LPS-activated and/or HIV-1-infected MCM-induced STAT3 activation and astrogliogenesis are partially through TNF-a.
A. NPCs were treated with TNF-a (20 ng/ml) for 1 min, 5 min, 10 min, 30 min, 4 h, 10 h, and 24 h. Expression of p-STAT3 and t-STAT3 was detected
by Western blotting. b-actin was used as a loading control. Results are representative of three independent experiments. B. NPCs were differentiated
in NB27 with 20% MCM with or without incubation with TNF-R1R2 (100 ng/ml) for 6 d. Expression of total-STAT3, phospho-STAT3, GFAP, and b-III-
tubulin was detected by Western blotting. Results are representative of three independent experiments. C–D. The films were scanned and the
acquired images were analyzed using the public domain NIH image program for data quantification. Expression of phospho-STAT3 (B) and GFAP (C)
were normalized to b-actin. Data is presented as fold of NB27 expression. Results are average of three independent donors. * p,0.05 in comparison
to NB27, # p,0.05 in comparison to no TNF-R1R2-treatment of the same condition.
doi:10.1371/journal.pone.0019439.g006
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STAT3, STAT3F, resulted in significantly increased expression of
proneural bHLH transcription factors, such as Math1, Ngn3, and
NeuroD and decreased expression of Notch1-3, Hes1, and Hes5
within the Notch pathway for gliogenesis [41]. A recent study,
using neural stem cell (NSC) isolated from STAT3
flox/flox mouse
embryos, also revealed that elimination of STAT3 in NSC
promoted neurogenesis and inhibited astrogliogenesis through the
down-regulation of notch1, notch2 and hes5 [38]. In our study, we
used siRNA-targeting STAT3 to down-regulate LPS-MCM and
LPS+HIV-MCM-induced STAT3 activation and subsequent
astrogliogensis. siSTAT3 also partially reversed LPS-MCM and
LPS+HIV-MCM-induced inhibition of neurogenesis.
In conclusion, we have demonstrated that HIV-1-infected and/
or immune activated MDM promote astrogliogenesis through the
secretion of cytokines such as TNF-a and that their effects are
Figure 7. siSTAT3 inhibits HIV-1-infected MDM-induced NPC astrogliogenesis. NPCs were transfected with siSTAT3 or sicon and labeled
with Qtracker. Cells were then intracranially injected into the basal ganglia of SCID mice with or without HIV-1ADA-infected MDM. Severn days after
injection, NPC differentiation was identified using immunostaining in serial 30 mm brain sections. A. Serial brain sections from mice injected with
sicon-NPC, sicon-NPC injected with HIV-1-infected MDM (sicon-NPC+HIVE), and siSTAT3-NPC+HIV-1-infected MDM (siSTAT3-NPC+HIVE) were
immunolabeled with antibodies to GFAP (red) and b-III-tubulin (green). Original magnification is 606. B-C. Neuronal or astrocytic differentiation was
quantified by determining the percentage of GFAP-positive or b-III-tubulin-positive cells. Data is presented as the mean 6 SEM and shown as the
percentage of GFAP-positive cells (B), and the percentage of b-III-tubulin-positive cells (C) in the injection area. * p,0.05 in comparison to sicon-NPC.
# p,0.05 in comparison to sicon-NPC+HIV-MDM.
doi:10.1371/journal.pone.0019439.g007
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suggest that brain inflammation disrupts neurogenesis in HAD.
NPCs have been experimentally used to repair the damaged
nervous system, either by transplantation of cells grown in vitro or
by activation of endogenous NPCs. A complete understanding of
how NPCs function under inflammatory conditions will allow us to
modulate the environment and devise therapeutic strategies to
enhance recovery from various CNS disorders. The interaction
between activated macrophage and the STAT3 pathway raises the
possibility that neuronal production in the brain can be regulated,
at least in part, by manipulation of the STAT3 pathway. This
pathway represents a potential drug target for promoting
endogenous neurogenesis for the treatment of patients suffering
from NeuroAIDS.
Supporting Information
Figure S1 Characterization of human cortical NPCs. A–
C. Human fetal cortical NPCs were expanded as neurosphere in
NPIM. Cells were dissociated and plated on poly-D-lysine-coated
cover slips for 24 h. Cells were fixed and stained for Nestin (red,
A). Nuclei were stained using Hoechst 33342 (blue, B). C shows
merge of A and B. Original magnification is 20 6. Results are
representative of two donors. D–I. NPCs were cultured in NPIM
overnight and were then treated with 20% LPS+HIV MCM in
NB27 for 24 h. Cells were immunolabeled with antibodies to
phospho-STAT3 (p-STAT3, red, E, F, H and I) and Nestin (green,
D and F) or astrocyte marker GFAP (green, G and I). Nuclei were
stained with Hoechst (blue in merged pictures F and I). Results are
representative of two independent experiments. Original magni-
fication is 40 6.
(TIF)
Figure S2 LPS-activated and/or HIV-1-infected MDM
induce cytokine production. A–I. HIV-1 infection. MDM
were infected with HIV-1ADA for 3–4 days and then stimulated
with LPS (100 ng/ml) for 3 h. Cells were stained with antibody to
p24 (HIV-1 infection marker, green), conjugated with anti-mouse
Alexa fluo 488 nm secondary antibody. Hoechst 33342 was used
for nuclear staining. A–C show control uninfected MDM. D–F
show HIV-1-infected MDM (HIV). G-I show LPS-activated and
HIV-1-infected MDM (HIV+LPS). Panels are representative of
three separate donors. Original magnification is 20 6. J. HIV-1
infection was quantified by determining the percentage of p24-
positive cells of seven to ten random microscopy fields. Data is
presented as the mean 6 SEM. K–M. HIV-infected and/or LPS-
activated MCM were collected and measured for levels of IL-6
(K), IL-1b (L), and TNF-a (M) by ELISA. Data is presented as the
mean 6 SD. Results represent the average of four donors. *
p,0.001 in comparison to con-MCM, # p,0.001 in comparison
to LPS-MCM.
(TIF)
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